Covovax EUA recommended for 12-17 group

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 last year. It is yet to be used in India’s vaccination drive.

Published: 05th March 2022 07:30 AM  |   Last Updated: 05th March 2022 07:30 AM   |  A+A-

A vaccine being loaded into a syringe

Image used for representational purpose only. (File photo | PTI)

By Express News Service

NEW DELHI: An expert panel of the Drugs Controller General of India (DCGI) has recommended granting emergency use authorisation (EUA) to Serum Institute of India’s Covid-19 vaccine Covovax for the 12-17 age group, officials said Friday. 

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 last year. It is yet to be used in India’s vaccination drive. The subject expert committee has given its recommendation to the DCGI for approval, officials added. At the moment, India is using only Bharat Biotech’s Covaxin to vaccinate children between 15-18 years.

The Pune-based pharma company had last month had submitted an application to the DCGI seeking for restricted emergency use of Covovax in adolescents. The SII has been developing Covovax through a technology transfer protocol from Novavax, already approved by the European Medicines Agency for conditional marketing authorisation. 



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp